Publications by authors named "Prathamesh Pathak"

Claim this Profile
C
Clinical Outcomes in Patients With Muscle-Invasive Urothelial Carcinoma Treated With Nivolumab.
Regina Barragán-Carrillo, Hedyeh Ebrahimi, William S John, Sarah Lucht, Taavy A Miller, Prathamesh Pathak

JAMA Netw Open· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world (RW) study of outcomes for acute myeloid leukemia (AML) patients treated with glasdegib or venetoclax in US community oncology practices.
Kristin M Zimmerman Savill, Jonathan K Kish, Choo Hyung Lee, Prathamesh Pathak, Paul D'Amico

Expert Rev Hematol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world use of tafasitamab preceding CD19-directed chimeric antigen receptor T-cell therapy for relapsed or refractory diffuse large B-cell lymphoma.
Narendranath Epperla, Loretta J Nastoupil, Bruce Feinberg, John Galvin, Prathamesh Pathak

Biomark Res· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world clinical outcomes and rationale for initiating abatacept as a first-line biologic for patients with anticitrullinated protein antibody- and rheumatoid factor-positive rheumatoid arthritis.
Alexandrina Balanean, Cherrishe Brown-Bickerstaff, Andrew Klink, Vardhaman Patel, Hanke Zheng, Prathamesh Pathak

J Comp Eff Res· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment patterns in patients with age-related macular degeneration and diabetic macular edema: A real-world claims analysis in Dubai.
Igor Kozak, Avinash Gurbaxani, Ammar Safar, Prasan Rao, Amal Masalmeh, Prathamesh Pathak

PLoS One· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-Line Fixed-Combination Psoriasis Treatment Is Associated With Lower Healthcare Costs.
Steven R Feldman, Eugenia Levi, Prathamesh Pathak, Sonali Kakatkar, Rajesh Balkrishnan

Skinmed· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health resource utilization and costs during the first 90 days following robot-assisted hysterectomy.
Vani Dandolu, Prathamesh Pathak

Int Urogynecol J· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing anticholinergic persistence and adherence profiles in overactive bladder patients based on gender, obesity, and major anticholinergic agents.
Lannah L Lua, Prathamesh Pathak, Vani Dandolu

Neurourol Urodyn· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative analysis of overall cost and rate of healthcare utilization among apical prolapse procedures.
Lannah L Lua, Erika D Vicente, Prathamesh Pathak, Daniel Lybbert, Vani Dandolu

Int Urogynecol J· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mesh complications and failure rates after transvaginal mesh repair compared with abdominal or laparoscopic sacrocolpopexy and to native tissue repair in treating apical prolapse.
Vani Dandolu, Megumi Akiyama, Gayle Allenback, Prathamesh Pathak

Int Urogynecol J· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using a single product (calcipotriene/betamethasone topical suspension) vs multiple products to manage body and scalp psoriasis: comparisons in resource utilization and costs.
Steven R Feldman, Eugenia Levi, Prathamesh Pathak, Sonali Kakatkar, Rajesh Balkrishnan

J Med Econ· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment pattern by hormone receptors and HER2 status in patients with metastatic breast cancer in the UK, Germany, France, Spain and Italy (EU-5): results from a physician survey.
Mitch DeKoven, Vijayveer Bonthapally, Xiaolong Jiao, Arijit Ganguli, Prathamesh Pathak

J Comp Eff Res· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Weighing the evidence for pediatric antipsychotic use.
Prathamesh Pathak, Donna West, Bradley C Martin

Psychiatr Serv· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence-based use of second-generation antipsychotics in a state Medicaid pediatric population, 2001-2005.
Prathamesh Pathak, Donna West, Bradley C Martin, Mark E Helm, Crystal Henderson

Psychiatr Serv· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost of hospital admission for antiarrhythmic drug initiation in atrial fibrillation.
Michael H Kim, David Klingman, Jay Lin, Prathamesh Pathak, David S Battleman

Ann Pharmacother· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis